Rovida Advisors’s Organon & Co OGN Stock Holding History

Rovida Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-45,149	Closed	-$1.37M	–	55
2021 Q2	$1.37M	Buy	+45,149	New	+$1.49M	0.06%	40

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rovida Advisors's OGN Position: Q3 2021 in Review

Rovida Advisors sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 45,149 shares — an estimated $1.37M sold.

Rovida Advisors first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $1.37M in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

Rovida Advisors reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
Rovida Advisors sold 45,149 Organon & Co shares in Q3 2021, an estimated $1.37M.
Rovida Advisors first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
Rovida Advisors's Organon & Co position peaked at $1.37M in Q2 2021.
928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Rovida Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.